Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Otsuka Holdings Co Ltd

+ Add to Watchlist

4578:JP

3,968.5 JPY 59.5 1.52%

As of 02:00:00 ET on 05/28/2015.

Snapshot for Otsuka Holdings Co Ltd (4578)

Open: 3,944.5 Day's Range: 3,927.5 - 3,976.5 Volume: 1,161,200
Previous Close: 3,909.0 52wk Range: 2,857.0 - 4,166.5 1-Yr Rtn: +38.79%

Stock Chart for 4578

No chart data available.
  • 4578:JP 3,961.0
  • 1D
  • 1M
  • 1Y
3,909.0
Interactive 4578 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4578

Current P/E Ratio (ttm) 14.8028
Estimated P/E(12/2015) 26.2625
Relative P/E vs. TPX 0.7802
Earnings Per Share (JPY) (ttm) 268.0920
Est. EPS (JPY) (12/2015) 151.1090
Est. PEG Ratio -
Market Cap (M JPY) 2,213,770.65
Shares Outstanding (M) 557.84
30 Day Average Volume 2,072,473
Price/Book (mrq) 1.3148
Price/Sale (ttm) 1.4194
Dividend Indicated Gross Yield 2.52%
Cash Dividend (JPY) 50.0000
Dividend Ex-Date 06/26/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4578

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4578

Otsuka Holdings Co Ltd is a pharmaceutical company. The Company manufactures, sells, imports and exports pharmaceuticals, clinical testing, and medical equipment for intractable diseases.

Ichiro OtsukaChairmanTatsuo HiguchiPresident/CEO
Atsumasa MakiseSenior Managing DirectorYoshiro MatsuoManaging Director
More Company Profile & Key Executives for 4578

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil